Literature DB >> 31075380

The Chinese herbal formulae (Yitangkang) exerts an antidiabetic effect through the regulation of substance metabolism and energy metabolism in type 2 diabetic rats.

Xueying Han1, Yufeng Yang1, Ahmed M Metwaly1, Yawei Xue1, Yan Shi2, Deqiang Dou3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Type 2 diabetes mellitus (T2DM) regarded as a "hot" disease in traditional Chinese medicine (TCM). Accordingly, TCM uses a cold drug or formula such as the Chinese herbal formulae "Yitangkang" (YTK) as a treatment. YTK exhibited a good clinical antidiabetic effect in several experiments. The correlation between the properties of a TCM drug or formula and its ability to regulate the substance metabolism, the energy metabolism and the endocrine system has been proven. AIM OF THE STUDY: The present study aiming to evaluate the mechanism of antidiabetic action of YTK from the above perspective.
MATERIALS AND METHODS: Three groups of streptozotocin (STZ)-diabetic rats have been treated with YTK at oral doses of 56 g/kg/d, 28 g/kg/d and 14 g/kg/d for 28 days using metformin as a reference drug. After treatment, several indices correlated with energy metabolism (superoxide dismutase, glutathione peroxidase, lactic dehydrogenase, adenotriphos, creatine phosphate kinase, AMPK, Na+-K+-ATPase and Respiratory Chain Complex I, II, III, IV), substance metabolism (hepatic glycogen, acetyl-coenzyme A, pyruvic acid, adipose triglyceride lipase, triglycerides, high-density lipoproteins, low-density lipoproteins, malonyldialdehyde), endocrine system (triiodothyronine, thyroxine, 17-hydroxycorticosteroid) and cyclic nucleotide system (cyclic adenosine monophosphate, cyclic guanosine monophosphate) have been determined. The specialty and tendency of YTK's effects were analyzed to elucidate its property and mechanism of action according to the theory of TCM.
RESULTS: Our findings showed that the formulae YTK could effectively regulate the levels of blood glucose, HbA1c, glucagon-like peptide-1, and significantly down-regulate the substance metabolism, energy metabolism and endocrine system indices of the diabetic rats.
CONCLUSION: These results were consistent with the TCM description of YTK as a "cold" treatment. It could provide an effective way to interpret the scientific connotation and comprehensive system of the Chinese herbal formulae.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Chinese herbal formulae; Energy metabolism; Substance metabolism; Type 2 diabetes mellitus; Yitangkang

Mesh:

Substances:

Year:  2019        PMID: 31075380     DOI: 10.1016/j.jep.2019.111942

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  9 in total

1.  Qingre Yiqi Method along with Oral Hypoglycemic Drugs in Treating Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Li Jiang; Shidong Wang; Jinxi Zhao; Weijun Huang; Jiayue Li; Yonghua Xiao; Hua Zhang; Qiang Fu; Yu Chen; Tao Yang; Esther Aijia Shen; Guanxun Su; Yaofu Zhang; Zhuang Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-11       Impact factor: 2.629

2.  Isolation and In Silico Anti-SARS-CoV-2 Papain-Like Protease Potentialities of Two Rare 2-Phenoxychromone Derivatives from Artemisia spp.

Authors:  Yerlan M Suleimen; Rani A Jose; Raigul N Suleimen; Christoph Arenz; Margarita Ishmuratova; Suzanne Toppet; Wim Dehaen; Aisha A Alsfouk; Eslam B Elkaeed; Ibrahim H Eissa; Ahmed M Metwaly
Journal:  Molecules       Date:  2022-02-11       Impact factor: 4.411

3.  Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease.

Authors:  Yerlan M Suleimen; Rani A Jose; Raigul N Suleimen; Christoph Arenz; Margarita Y Ishmuratova; Suzanne Toppet; Wim Dehaen; Bshra A Alsfouk; Eslam B Elkaeed; Ibrahim H Eissa; Ahmed M Metwaly
Journal:  Molecules       Date:  2022-03-01       Impact factor: 4.411

4.  Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from Artemisia glauca.

Authors:  Yerlan M Suleimen; Rani A Jose; Raigul N Suleimen; Margarita Y Ishmuratova; Suzanne Toppet; Wim Dehaen; Aisha A Alsfouk; Eslam B Elkaeed; Ibrahim H Eissa; Ahmed M Metwaly
Journal:  Molecules       Date:  2022-03-31       Impact factor: 4.411

5.  Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease.

Authors:  Eslam B Elkaeed; Fadia S Youssef; Ibrahim H Eissa; Hazem Elkady; Aisha A Alsfouk; Mohamed L Ashour; Mahmoud A El Hassab; Sahar M Abou-Seri; Ahmed M Metwaly
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

6.  The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from Tagetes patula, against SARS-CoV-2.

Authors:  Ahmed M Metwaly; Eslam B Elkaeed; Bshra A Alsfouk; Abdulrahman M Saleh; Ahmad E Mostafa; Ibrahim H Eissa
Journal:  Plants (Basel)       Date:  2022-07-20

7.  Combined Computational and Experimental Studies of Anabasine Encapsulation by Beta-Cyclodextrin.

Authors:  Zeinolla Muldakhmetov; Serik Fazylov; Oral Nurkenov; Arstan Gazaliev; Akmaral Sarsenbekova; Irina Pustolaikina; Zhangeldy Nurmaganbetov; Olzhas Seilkhanov; Aisha A Alsfouk; Eslam B Elkaeed; Ibrahim H Eissa; Ahmed M Metwaly
Journal:  Plants (Basel)       Date:  2022-08-31

8.  Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-O-(6″-O-acetyl)-Glucoside from Calligonum tetrapterum.

Authors:  Yerlan M Suleimen; Rani A Jose; Gulnur K Mamytbekova; Raigul N Suleimen; Margarita Y Ishmuratova; Wim Dehaen; Bshra A Alsfouk; Eslam B Elkaeed; Ibrahim H Eissa; Ahmed M Metwaly
Journal:  Plants (Basel)       Date:  2022-08-08

9.  A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease.

Authors:  Eslam B Elkaeed; Ibrahim H Eissa; Hazem Elkady; Ahmed Abdelalim; Ahmad M Alqaisi; Aisha A Alsfouk; Alaa Elwan; Ahmed M Metwaly
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.